CRESTONE, INC.

Basic Information

12635 E. Montview Blvd
AURORA, CO, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 15881952
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Optimization and Lead Selection of Novel Antimycobacterial Agents

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): The non-tuberculous mycobacteria (NTM) are a growing public health concern as the number of opportunistic infections increases. Although not a reportable disease, ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Development of a Novel PolC Inhibitor as a Gram-Positive Antibiotic

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We are developing a nov ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Novel DNA Polymerase Inhibitors as Gram-Positive Antibacterial Agents

    Amount: $991,909.00

    DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We have discovered and ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government